Nikos Koundouros, a postdoctoral fellow at Weill Cornell Medicine, joins John Blenis, a prominent pharmacology professor, to unravel how omega-6 fatty acids like linoleic acid may drive triple-negative breast cancer by activating the mTOR pathway. They discuss the critical role of the FABP5 protein, uniquely enhancing cancer cell sensitivity to these fats. The conversation reveals alarming shifts in modern diets, emphasizing the need for tailored nutrition approaches based on genetic variations and cancer subtypes to improve health outcomes.
01:47:18
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
mTOR is the Cell's Brain
mTOR acts as the brain of the cell, sensing nutrients and regulating growth.
Dysregulated mTOR leads to uncontrolled anabolism contributing to cancer development.
insights INSIGHT
Cancer Boosts Nutrient Uptake
Cancer cells enhance nutrient uptake by increasing transporter expression to fuel growth.
Genetic mutations can amplify mTOR signaling to sustain growth even under low nutrient conditions.
insights INSIGHT
Triple Negative Breast Cancer Explained
Triple-negative breast cancers lack estrogen, progesterone, and HER2 receptors.
They are more aggressive and lack targeted therapies, making treatment challenging.
Get the Snipd Podcast app to discover more snips from this episode
Episode Summary: New research on how dietary fats, particularly omega-6 fatty acids like linoleic acid, influence triple-negative breast cancer progression by activating the mTOR pathway, a key regulator of cell growth; role of the FABP5 protein in enhancing cancer cells’ sensitivity to omega-6 fats; differences between breast cancer subtypes; broader implications of dietary balance for health.
About the guest: John Blenis, PhD is a Professor of Pharmacology at the Meyer Cancer Center at Weill Cornell Medicine. Nikos Koundouros, PhD is a postdoctoral fellow in Blenis’ lab.
Note: Podcast episodes are fully available to paid subscribers on the M&M Substack and everyone on YouTube. Partial versions are available elsewhere. Transcript and other information on Substack.
Key Points:
mTOR pathway acts as a cellular “brain,” sensing nutrients like amino acids, glucose, and fats to regulate growth. Its dysregulation can drive cancer.
High dietary omega-6 fatty acids, like linoleic acid found in seed oils, can fuel triple-negative breast cancer growth by activating mTOR.
FABP5, a lipid chaperone protein, is overexpressed in triple-negative breast cancer, making these tumors more sensitive to omega-6 fats, suggesting its potential as a therapeutic target.
Modern diets with high omega-6 to omega-3 ratios disrupt inflammation balance, unlike historical 1:1 ratios, potentially increasing cancer risk.
Genetic variations and cancer subtypes highlight the need for tailored dietary recommendations, as blanket nutrition advice may not suit all patients.
While omega-6 fats exacerbate existing triple-negative breast cancer, their role in initiating cancer remains unclear, requiring further study.
High omega-6 intake may influence other cancers (e.g., prostate, colon) and chronic diseases like obesity, linked to FABP5 and inflammation.
Related episode:
M&M 200: Dietary Fats & Seed Oils in Inflammation, Colon Cancer & Chronic Disease | Tim Yeatman & Ganesh Halade
All episodes, show notes, transcripts, and more at the M&M Substack
Affiliates:
KetoCitra—Ketone body BHB + potassium, calcium & magnesium, formulated with kidney health in mind. Use code MIND20 for 20% off any subscription (cancel anytime)
Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off
Readwise: Organize and share what you read. 60 days FREE through link
SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount.
MASA Chips—delicious tortilla chips made from organic corn & grass-fed beef tallow. No seed oils or artificial ingredients. Code MIND for 20% off